Zenith Drugs Limited was originally incorporated on November 15, 2000 as a Private Limited Company in the name of ‘Zenith Drugs Private Limited’ under the provisions of the Companies Act, 1956 with the Registrar of Companies, Madhya Pradesh, Gwalior. Subsequently pursuant to a Special Resolution of its Shareholders passed in the Extra-Ordinary General Meeting held on September 05, 2023, the Company was converted from a Private Limited Company to Public Limited Company and consequently, the name of the Company was changed to ‘Zenith Drugs Limited’ and a Fresh Certificate of Incorporation consequent to Conversion was issued on September 13, 2023 by the Registrar of Companies, Gwalior.

The company is a pharmaceutical manufacturing and trading company based out from Indore. It has a manufacturing unit, dedicated to ensuring the highest quality standards when it comes to manufacturing of medicines. It is specialized in manufacturing high quality and affordable Medicines to support its patients in need. The company is also into Generic Medicines and Generic Medicines are cost effective. Since its inception, the company has focused on building a strong foundation and laying the groundwork for its future growth and success. With dedication and strategic planning, it managed to establish a reputable presence in the pharmaceutical industry. The company was incorporated with the objective of the better service deliverance in field of medicine and be better premium pharmaceutical companies in India and abroad for cost effective human medicine. The company always emphasis on core strength and policies that focus on technology and great deliverance. With a passion to set high standards of services, the company has always taken all measures to scale up as and when required only to deliver the better. The company works diligently and has a wide range of products to cater to every need and to reach the client sensitivity and centricity.

The company has Certificate of Good Manufacturing Practices issued by Office of the Controller, Food and Drugs Administration, Madhya Pradesh, Idgah Hills, Bhopal, Madhya Pradesh. The quality standards of the company are based on adherence to Good Manufacturing Practices (GMP) guidelines, regulatory requirements and internal quality control processes. The Company is constantly required to adhere to the same. These measures are implemented to ensure the highest level of quality in its manufacturing operations. Building upon its commitment to excellence, it has completed two expansions within the same facility to accommodate the growing demand for its products. These expansions have allowed the company to scale its operations, increase production capacity, and introduce new formulations. Through these strategic investments and expansions, the company strives to continuously improve its manufacturing infrastructure, enhance product quality, and meet the evolving needs of healthcare professionals and patients.

Business area of the company

The company is mainly engaged in the business of manufacturing and Trading of Medicines.

Products of the company

Liquid oral

• Iron & Folic acid syrup IP
• Hungrykop syrup
• BIozen multivitamin syrup
• Rexkop DX syrup
• Zoomol plus syrup

Ointment / Cream

• POVIZ ointment
• Clobetol GM cream
• Painfree gel
• Poviz M ointment
• Candizen cream

Liquid external section

• Poviz solutin (Lotion)
• Bioscaby lotion
• Permethirn lotion
• Gamma Benzene Hexachloride 1% lotion
• Scabikop lotion

Capsule section

• Pyvoxee spas plus capsule
• BIO-Omi capsule
• Lopagen capsule
• Cold-time capsule
• Rabijen DSR capsule

ORS section

• Zenith ORS
• Koplyte ORS
• Oral rehydration salts IP 20.50 gm
• Oral rehydration salts BP 27.90 gm

History and milestones

• 2000: Incorporation of the Company.
• 2001: Started as a manufacturing house for oral and external formulations.
• 2004: Shifted to a Schedule M GMP compliant unit.
• 2004: Started the production of two lines which are liquid orals and ointments.
• 2007: Started manufacturing ORS Powder.
• 2016: Received WHO GMP certification.
• 2019: Turnover crossed Rs 50 crore.
• 2020: Turnover crossed Rs 75 crore.
• 2021: Certificate of Quality Management System ISO 9001:2015 issued by Global Grading Certification.
• 2021: Certificate of compliance with good manufacturing practices issued by Liberia Medicines and Health Products Regulatory Authority.
• 2021: The Company received subsidy under Madhya Pradesh MSME Yojna i.e. MSME Promotion Scheme, 2019 as Industrial Development Grant upto 40% of the capital invested in machinery i.e. grant of Rs 170.04 lakh.
• 2022: The Company was recognized as among top 10 MSME Pharmaceutical Manufacturers in Indore in Industry Outlook Magazine Edition.
• 2023: Turnover crossed Rs 100 crore.
• 2023: Collaborated with Mr. Kshatriya Valtaprasad Nandkishore for Carrying out the task of Marketing and Export of the products manufactured by Zenith.
• 2023: Conversion of the Company from Private Limited Company to Public Limited Company.